Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 24: Sirolimus- vs. Paclitaxel-Coated Balloon Angioplasty
Author(s): Ulf Teichgräber Added: 6 months ago
TCT Conference 2024 - Safety and efficacy outcomes of the trial shows that percutaneous transluminal angioplasty (PTA) with the sirolimus drug coated balloon (DCB) in patients with femoropopliteal artery disease was/was not noninferior to PTA with the paclitaxel DCB.Prof Ulf Teichgräber joins us onsite at TCT Conference to discuss the findings from the sirolimus- vs. paclitaxel-coated balloon… View more

Vascular Disease and Surgery

Intervention
TCT 24: The ECLIPSE Trial
Author(s): Ajay J Kirtane Added: 6 months ago
TCT Conference 2024 - Routine use of orbital atherectomy system (OAS) did not improve minimal stent area (MSA) or target vessel failure (TVF) at one year compaared to conventional balloon angioplasty.Dr Ajay J Kirtane (Columbia University Medical Center and New York-Presbyterian Hospital, New York, US) joins us onsite at TCT Conference to discuss the findings from ECLIPSE (NCT03108456; Abbott… View more

Intervention
TCT 23: AGENT IDE
Author(s): Robert Yeh Added: 1 year ago
TCT 23 - In this short online interview, we are joined by Dr Robert Yeh (Beth Israel Deaconess Medical Center, US) to discuss the findings of the AGENT IDE trial (NCT04647253), sponsored by Boston Scientific. AGENT IDE is a prospective, 2:1 randomized multicenter trial that aimed to compare the AGENT paclitaxel-coated balloon to plain-old balloon angioplasty (POBA) with a commercially available… View more

Intervention
ACC.24: The SMART Trial
Author(s): Howard C Herrmann Added: 1 year ago
ACC.24 — Investigator, Dr Howard C Hermann (Penn Medicine, Philadelphia, PA, US) joins us to discuss the findings from the SMART Trial (NCT04722250).This prospective, multi-center, randomized controlled study aims to investigate the valve safety and performance of self expanding as compared to balloon-expandable transcatheter aortic valve replacement (TAVR) in patients with small aortic annuli… View more

Intervention
Repeat TAVR Outcomes: Promising Results for Selected Patients with Failed TAVR
Author(s): Raj Makkar Added: 1 year ago
In this insightful interview, investigator, Prof Raj R Makkar(Cedars-Sinai Heart Institute, US) joins us to discuss the outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves. Prof Makkar and his team used the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry to address a series of questions regarding the safety… View more

Intervention
EuroPCR 24: 5-year Results of the SOLVE-TAVI trial
Author(s): Hans-Josef Feistritzer Added: 1 year ago
EuroPCR 24 - In this succinct interview, we are joined by Dr Hans-Josef Feistritzer (University of Leipzig, DE) to discuss the findings of the SOLVE-TAVI Trial.In recent years, trials such as CHOICE, REPRISE III, the SCOPE trial, PORTICO IDE and the SMART trial have privided increasing evidence for direct TACI valve comparisons as device designs improve. TAVI is increasingly performed using local… View more

Intervention
Vineet Agrawal
Job title: Assistant Professor of Medicine
Personal History Dr Vineet Agrawal is a physician-scientist and is Assistant Professor of Medicine at the Vanderbilt University Medical Center. He is from Omaha, Nebraska.1, 2, 5 Academic History In 2006, Dr Agrawal completed his undergraduate training at Duke University in Biomedical and Electrical Engineering. In 2012, he completed his MD and PhD in the Medical Scientist Training… View more
Research Area(s) / Expertise: Job title: Interventional Cardiologist
Dr Mir Basir is an Interventional Cardiologist at the Henry Ford Hospital in Detroit, Michigan, US.Dr Basir specialises in the treatment of complex heart blockage with minimally invasive techniques using balloons and stents. He is a national leader in the treatment of cardiogenic shock and lectures around the world on the use of temporary heart pumps when the heart is failing. View more
SUCCESS PTA: 12-Month Data from SELUTION SLR™ DEB
Author(s): Michael Lichtenberg Added: 3 weeks ago
12 Month Outcomes of the SUCCESS PTA Study show consistent safety and effectiveness in claudicant and CLTI patients when using the SELUTION SLR™ drug eluting balloon.Dr Michael Lichtenberg (Vascular Centre Clinic Arnsberg, Arnsberg, DE) joins us to discuss the SUCCESS PTA study, a prospective, observational global registry evaluating the SELUTION SLR DEB in 723 patients across Europe, Asia and… View more

Intervention

Vascular Disease and Surgery
Cardio-obstetrics in the CICU: An Introductory Guide
Author(s): Jenna Skowronski , Eleanor Christenson , Kayle Shapero , et al Added: 1 month ago

CV Disease in Special Populations

Heart Failure